Skip to main content

Advertisement

Table 1 Anthropometric characteristics, fasting values of all subjects (n = 34) at the end of each intervention period.

From: Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARγ2 P12A polymorphism: a double blind, randomized, controlled cross-over study

Preparation linoleic acid CLA MIX cis-9,trans-11 CLA trans-10,cis-12 CLA P
Weight (kg) 84.2 (± 2.0) 84.2 (± 2.0) 84.1 (± 2.0) 84.0 (± 2.0) 0.851
BMI (kg/m2) 26.1 (± 0.5) 26.1 (± 0.4) 26.0 (± 0.4) 26.0 (± 0.5) 0.900
Waist (cm) 102.1 (± 1.5)a 102.1 (± 1.6)a 102.3 (± 1.5) a 101.2 (± 1.5) b 0.072
Hip (cm) 104.8 (± 1.0) 104.8 (± 1.0) 104.8 (± 1.0) 104.0 (± 1.0) 0.824
Waist/hip ratio 0.97 (± 0.01) 0.97 (± 0.01) 0.98 (± 0.01) 0.97 (± 0.01) 0.645
Plasma glucose (mg/dl) 96.5 (± 1.4) 98.2 (± 1.5) 97.5 (± 1.5) 96.5 (± 1.4) 0.487
HOMA-IR 3.0(± 0.3) 3.2(± 0.2) 3.1(± 0.3) 2.9(± 0.2) 0.693
Triacylglycerols (mg/dl) 127.0 (± 10.1) 119.1 (± 8.9) 124.4 (± 10.8) 124.7 (± 10.6) 0.787
Total cholesterol (mg/dl) 223.9(± 7.3) 225.3(± 6.8) 223.6(± 7.2) 226.5(± 6.8) 0.783
LDL cholesterol (mg/dl) 56.3(± 2.6) 56.5(± 2.3) 56.7(± 2.5) 54.6(± 2.8) 0.268
HDL cholesterol (mg/dl) 145.4(± 6.0) 143.1(± 5.8) 145.7(± 6.3) 146.4(± 5.7) 0.772
SBP (mmHg) 127 (± 3) 127 (± 3) 128 (± 3) 126 (± 2) 0.901
DBP (mmHg) 80(± 2) 79 (± 2) 80 (± 2) 80 (± 2) 0.871
  1. Values are expressed as mean ± SEM. CLA, conjugated linoleic acid; BMI, body mass index, DBP diastolic Blood pressure, SBP systolic blood pressure LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, HOMA-IR; homeostasis model assessment-insulin resistance, intervention-dependent changes were compared using multiple ANOVA.